www.allsides.com
Trump announces lower prices, Medicare coverage for popular weight-loss drugs
President Donald Trump announced a deal Thursday, Nov. 6 with drugmakers Eli Lilly and Novo Nordisk to cut prices of their popular weight-loss drugs and expand Medicare coverage of these medications for older adults.
The negotiated deals will allow Medicare and Medicaid coverage for Lilly's Zepbound and Novo's Wegovy, and consumers will be able to purchase drugs at discounted prices through the federal government's direct-to-consumer website, TrumpRx, which will launch in 2026...
New Posts (Home)
ChatBox
Popular Posts 
Game Zone
Top PodCasts
